• EnderMB@lemmy.world
    link
    fedilink
    arrow-up
    7
    ·
    9 个月前

    I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.

    The problem still stands, though, and the solution is capping executive pay in public companies.